In pituitary (Hibberts et al, 1999; Simpson et al, 2001) and ovarian (Dhar et al, 1999) tumours, cytoplasmic cyclin D1 has been reported (35 and 59% of cyclin D1-positive cases, respectively) but no correlations were identified. This evidence concerns the gene CCND1 and neoplasm.